gimli
MASTEK stock AI analysis

MASTEK Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

MASTEK LTD is a small-cap stock in Information Technology. This Gimli page shows the latest available MASTEK price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Price
₹1,588.20
1W return
-1.35%
1M return
-7.53%
3M return
-2.93%
6M return
+3.38%
1Y return
-35.55%
Market cap
₹4,923.55 cr
PE
11.78
PB
1.65
ROE
+15.32%
ROCE
+13.16%
RSI
39.18
Turnover
₹31.89 cr

Why it can matter in screens

Quick Answers

What is the latest MASTEK stock price?

The latest stored price for MASTEK is Rs 1,588.20 as of 2026-09-18.

Is MASTEK above its 50DMA and 200DMA?

MASTEK is below 50DMA, below 200DMA. The latest 50DMA is 1,746.44 and the latest 200DMA is 1,773.85.

What are MASTEK PE, ROE and ROCE?

MASTEK has PE 11.78, ROE +15.32%, and ROCE +13.16% in Gimli's latest available snapshot.

How has MASTEK performed recently?

MASTEK has returned -7.53% over 1 month, -2.93% over 3 months, and -35.55% over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

PeriodRevenueEBITDAPATEPS
2026-06-30985.25 cr163.39 cr105.88 cr34.16
2026-03-31938.00 cr150.89 cr106.15 cr34.25
2025-12-31905.68 cr166.48 cr108.35 cr34.97
2025-09-30955.46 cr160.60 cr97.45 cr31.24
2025-06-30914.70 cr147.88 cr92.05 cr29.75
2025-03-31905.42 cr134.20 cr81.07 cr26.24
2024-12-31869.53 cr154.10 cr94.71 cr30.68
2024-09-30867.39 cr159.91 cr128.65 cr41.69

Annual income statement

YearRevenueEBITDAPATEPS
2026-03-313,698.75 cr625.85 cr404.00 cr130.45
2025-03-313,455.23 cr576.34 cr375.93 cr121.78
2024-03-313,049.24 cr518.66 cr300.29 cr98.01
2023-03-312,558.20 cr519.15 cr293.01 cr97.23
2022-03-31330.24 cr496.59 cr77.11 cr27.13

Balance sheet

PeriodAssetsCashDebtEquity
2026-03-314,308.83 cr704.33 cr438.26 cr2,991.85 cr
2025-03-313,861.88 cr460.76 cr583.13 cr2,462.34 cr
2024-03-313,685.13 cr381.12 cr518.96 cr2,087.41 cr
2023-03-313,140.90 cr207.64 cr404.23 cr1,774.51 cr
2022-03-312,488.17 cr726.58 cr202.83 cr1,221.70 cr

Cash flow

PeriodOCFFCFCash change
2026-03-31541.69 cr513.70 crn/a
2025-03-31396.39 cr376.26 crn/a
2024-03-31420.37 cr388.92 crn/a
2023-03-31107.67 cr76.17 crn/a
2022-03-31273.49 cr236.64 crn/a

Shareholding Trend

PeriodPromoterFII/FPIDIIMFRetailPledge
2026-06-30+35.76%+7.45%+19.86%+15.50%+36.93%+0.00%
2026-03-31+35.76%+8.03%+19.03%+14.94%+37.18%+0.00%
2025-12-31+35.77%+10.26%+12.65%+7.74%+41.31%+0.00%
2025-09-30+35.79%+11.24%+11.53%+6.30%+41.44%+0.00%
2025-06-30+35.95%+11.04%+10.52%+5.22%+42.48%+0.00%
2025-03-31+35.97%+10.01%+9.85%+4.77%+44.18%+0.00%
2024-12-31+36.22%+9.39%+9.28%+4.02%+45.11%+0.00%
2024-09-30+36.23%+8.13%+10.41%+5.10%+45.22%+0.00%
2024-06-30+36.25%+14.04%+7.11%+2.20%+42.60%+0.00%
2024-03-31+36.26%+14.40%+7.06%+2.11%+42.27%n/a
2023-12-31+36.47%+14.10%+6.41%+1.61%+43.02%n/a
2023-09-30+36.50%+13.93%+5.99%+1.40%+43.58%+0.00%
2023-06-30+36.57%+13.42%+5.86%+1.12%+44.15%+0.00%
2023-03-31+36.75%+13.14%+4.80%+0.96%+45.31%+0.00%
2022-12-31+37.27%+13.25%+3.90%+0.33%+45.58%+0.00%
2022-09-30+37.28%+13.04%+3.73%+0.32%+45.95%+0.00%
2022-06-30+37.31%+0.00%+13.72%n/an/a+0.00%
2022-03-31+37.30%+0.00%+13.27%n/an/a+0.00%
2021-12-31+37.59%+0.00%+12.06%n/an/a+0.00%
2021-09-30+37.75%+0.00%+12.15%n/an/a+0.00%

Industry Peers

SymbolNameMcapPEROE1Y
TCSTATA CONSULTANCY SERV LT761,607.42 cr15.276450+48.82%-33.74%
INFYINFOSYS LIMITED425,502.41 cr16.930770+23.83%-31.75%
HCLTECHHCL TECHNOLOGIES LTD338,017.15 cr21.332733+21.87%-16.37%
WIPROWIPRO LTD174,923.06 cr13.232700+15.39%-35.07%
TECHMTECH MAHINDRA LIMITED136,143.79 cr26.472183+17.77%-0.88%
LTMLTM LIMITED126,740.13 cr24.325386+22.26%-22.62%
OFSSORACLE FIN SERV SOFT LTD.103,569.43 cr30.346459+42.16%+29.66%
PERSISTENTPERSISTENT SYSTEMS LTD84,614.71 cr43.996376+27.17%-2.72%

Try these prompts

Related screen ideas

Data snapshot: 2026-09-18. Not investment advice.